The independent platform for news, articles and advice for professionals in laboratory medicine

Haemorheology and diabetes – what clinical viscosity could tell us

It has been long established that circulatory and vascular changes play a significant role in long-term complications of diabetes. David Norcliffe and David Manuel explore how clinical viscosity testing could play a role in the care pathways of diabetes patients.

Diabetes is an endocrine disorder characterised by high blood sugar levels. Diabetes is a chronic disease that occurs either when the pancreas produces insufficient insulin or when the body cannot effectively use the insulin it produces.1 The International Diabetes Federation (IDF, 2021) diabetes atlas reports that, 537 million (10.5%) of the adult population (aged 20-79) has diabetes. IDF projection show that 1 in 8 adults, approximately 783 million, will be living with diabetes by 2045.2

Diabetes mellitus3 was named in 1675 by Thomas Willis, though the symptoms were described as far back as the ancient Egyptians. The name derives from diabetes meaning ‘pass through’ and mellitus meaning ‘sweet’ at a time when the diagnosis was made by tasting the urine of diabetic patients for sweetness. It currently represents one of the largest patient populations and can be broadly classified as two types:4 type 1 where the pancreas secretes insufficient insulin due to the body’s immune system attacks and destroy the cells that produce insulin, and type 2 where a resistance to insulin occurs. Further subtypes, up to six categories, exist such as gestational, maturity onset, ketosis prone and hybrid.

Diagnosis and monitoring have seen significant landmarks since it was first described. Arguably the most significant of recent times was the discovery of HbA1c in the early 1970s; the author being one of the first in the UK to measure it and provide a monitoring service in 1979 in Sheffield. Commercial companies further developed the technique, and a comparison was made of the methods available at the time.5 HbA1c6 reflects the mean blood glucose over the preceding approximate 120 days and by maintaining the level within reference limits is thought to reduce the likelihood of the long-term clinical consequences of poor control by avoiding spikes in blood glucose. 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.
Register

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025